BONUS CAP ZERTIFIKAT - GILEAD SCIENCES Stock

Certificat

DE000VM4JKT0

Market Closed - Deutsche Boerse AG 14:07:52 2024-05-28 EDT
66.59 EUR -5.28% Intraday chart for BONUS CAP ZERTIFIKAT - GILEAD SCIENCES
Current month-3.73%
1 month-3.94%
Date Price Change
24-05-28 66.59 -5.28%
24-05-27 70.3 +0.72%
24-05-24 69.8 -2.10%
24-05-23 71.3 -4.44%
24-05-22 74.61 +2.33%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 02:07 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying GILEAD SCIENCES, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM4JKT
ISINDE000VM4JKT0
Date issued 2023-10-26
Strike 100 $
Maturity 2024-12-20 (206 Days)
Parity 1 : 1
Emission price 76.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 83.84
Lowest since issue 66.43
Spread 0.31
Spread %0.47%

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
63.94 USD
Average target price
82.77 USD
Spread / Average Target
+29.46%
Consensus